Clinical Trials Logo

Compulsive Sexual Behavior clinical trials

View clinical trials related to Compulsive Sexual Behavior.

Filter by:
  • None
  • Page 1

NCT ID: NCT06408545 Recruiting - Clinical trials for Compulsive Sexual Behavior

Acceptance and Commitment Therapy for Problematic Chemsex

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex. As a pilot study, the intervention will be tested in a small group.

NCT ID: NCT06406296 Not yet recruiting - Clinical trials for Compulsive Sexual Behavior

Effectiveness of ACT for Problematic Chemsex

ChemACT
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex.

NCT ID: NCT05572372 Completed - Clinical trials for Compulsive Sexual Behavior

Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality

Start date: January 8, 2022
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of hypersexuality.

NCT ID: NCT04634175 Enrolling by invitation - Clinical trials for Compulsive Sexual Behavior

Mind-body Intervention for Compulsive Sexual Behavior Disorder

CSBD
Start date: July 15, 2021
Phase: N/A
Study type: Interventional

Mind-body intervention as a complementary and integrative treatment for compulsive sexual behavior disorder. The hypothesis is that participants with CSBD, after being submitted to the protocol of the mind-body intervention group in relation to those submitted to the intervention protocol Shan of the control group, present less severe sexual compulsiveness.

NCT ID: NCT03495414 Completed - Clinical trials for Compulsive Sexual Behavior

Neurobiological Underpinnings to Hypersexual Disorder

Start date: April 1, 2018
Phase:
Study type: Observational

Hypersexual Disorder (HD), sometimes called "sexual addiction", is a disorder with intense sexual desires and psychological preoccupations that lead to out-of-control sexual activities with severe consequences. HD is related to higher risks of HIV infection and an important risk factor for committing sexual crimes. The prevalence of HD is 3-6% of the general population, thus, a significant burden for society. The neurobiological mechanisms behind HD are still unknown, and there is still a great need for causal treatments. This study is aimed at identifying neurobiological and psychological mechanisms underlying HD as a basis for treatment development. The overall goal is to improve mental health, quality of life, diagnosis and treatment options for affected individuals, and to reduce the impact HD can have on society. Patients with HD will be recruited at Karolinska University Hospital in close collaboration between endocrinologists, psychologists, psychiatrists, and brain researchers at Karolinska Institutet. Cases and healthy controls will undergo brain scans (MRI), psychological and blood tests to quantify neurobiological, cognitive, and behavioral aspects of HD. This study is directly integrated into clinical practice, can identify important targets for interventions and factors predicting treatment outcomes. This study is essential for a better understanding of HD, the improvement of treatments, and can have significant impact on the prevention of HIV infections and sexual crimes.

NCT ID: NCT02300051 Completed - Clinical trials for Compulsive Sexual Behavior

Intervention Study for Individuals With Compulsive Sexual Behavior

Start date: February 2011
Phase: N/A
Study type: Interventional

The purpose of this study is compare three interventions (short-term psychodynamic psychotherapeutic group and relapse prevention group therapy vs. treatment as usual, namely, psychiatric follow up including prescription of medication vs. both interventions combined) to individuals presenting compulsive sexual behavior.

NCT ID: NCT00467558 Completed - Clinical trials for Compulsive Sexual Behavior

Double-Blind Naltrexone in Compulsive Sexual Behavior

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.